SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-20-010599
Filing Date
2020-05-13
Accepted
2020-05-13 16:37:30
Documents
63
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q dmtp20200331_10q.htm 10-Q 524528
8 EXHIBIT 31.1 ex_184772.htm EX-31.1 12401
9 EXHIBIT 31.2 ex_184813.htm EX-31.2 12283
10 EXHIBIT 32.1 ex_184814.htm EX-32.1 4529
11 EXHIBIT 32.2 ex_184817.htm EX-32.2 4460
12 diagraph.jpg GRAPHIC 35271
  Complete submission text file 0001437749-20-010599.txt   3205420

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT dmac-20200331.xml EX-101.INS 571182
3 XBRL TAXONOMY EXTENSION SCHEMA dmac-20200331.xsd EX-101.SCH 43107
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dmac-20200331_cal.xml EX-101.CAL 30794
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dmac-20200331_def.xml EX-101.DEF 251028
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE dmac-20200331_lab.xml EX-101.LAB 218884
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dmac-20200331_pre.xml EX-101.PRE 276199
Mailing Address 2 CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447
Business Address 2 CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447 (763) 496-5454
DiaMedica Therapeutics Inc. (Filer) CIK: 0001401040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36291 | Film No.: 20873684
SIC: 2834 Pharmaceutical Preparations